Gemina Labs Nears Completion of Phase 2 Human Patient Testing for Initial Diagnostic Test

Author's Avatar
Apr 28, 2022

VANCOUVER, BC / ACCESSWIRE / April 28, 2022 / Gemina Laboratories Ltd. (CSE:GLAB) (FRA:8I7, Financial) (the "Company" or "Gemina") is pleased to announce that human subject testing for its COVID-19 rapid antigen test is in its final stages, with completion and full data readout expected in May 2022.